K'NELL ENGLE: Open Payments
NPI 1194153163 · PLAINVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 67 payments from 10 companies in 2025. Trend: 2023 $1,761 · 2024 $1,725 · 2025 $1,305
Food & beverage: $1,305
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 27 | $484 |
| AstraZeneca Pharmaceuticals LP | 8 | $241 |
| Verona Pharma, Inc. | 14 | $204 |
| Amgen Inc. | 7 | $118 |
| Grifols USA, LLC | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Viatris Specialty LLC | 2 | $58 |
| ABBVIE INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
Products named: TRELEGY ELLIPTA, TEZSPIRE, Ohtuvayre, FASENRA, NUCALA, Prolastin-C Liquid, DUPIXENT, YUPELRI.
Industry payments across TX — which companies pay providers there.
